|
DNLI
|
Denali Therapeutics Inc.
|
0.47%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.47%
|
US
|
NASDAQ
|
|
EVT
|
Evotec SE
|
0.46%
|
DE
|
XETRA
|
|
0853
|
MicroPort Scientific Corp
|
0.46%
|
HK
|
HK
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.43%
|
US
|
NASDAQ
|
|
EKTA-B
|
Elekta AB (publ)
|
0.42%
|
SE
|
ST
|
|
BAVA
|
Bavarian Nordic
|
0.42%
|
DK
|
CO
|
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
0.41%
|
US
|
NASDAQ
|
|
EVH
|
Evolent Health, Inc
|
0.40%
|
US
|
NYSE
|
|
MDRX
|
Allscripts Healthcare Solutions, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
ONT
|
Oxford Nanopore Technologies Ltd
|
0.37%
|
UK
|
LSE
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
SECT-B
|
Sectra AB (publ)
|
0.35%
|
SE
|
ST
|
|
ATRC
|
AtriCure, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.35%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.34%
|
US
|
NASDAQ
|